Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Insulin-Like Growth Factor 1 (IGF-1) Mediates the Effects of Enriched Environment (EE) on Visual Cortical Development

Open access

Abstract

Enriched environment (EE) has been recently shown to affect visual cortex development and plasticity, and to prevent dark rearing effects. The factors mediating EE effects on visual cortical development and plasticity are still unclear. We have investigated whether IGF-1 is involved in mediating EE effects on the developing visual cortex. We show that EE increases the number of IGF-1 positive neurons in the visual cortex at P18. Increasing IGF-1 in the visual cortex of non-EE rats by means of osmotic minipumps implanted at P18 mimics EE effects, accelerating visual acuity development, assessed with Visual Evoked Potentials (VEPs). Blocking IGF-1 action in the visual cortex of EE rats by means of the IGF-1 receptor antagonist JB1 from P18 completely blocks EE action on visual acuity development. These results show that IGF-1 is a key factor mediating EE effects on visual cortical development. We then show that IGF-1 affects GAD65 immunoreactivity in perisomatic innervation and the condensation of Chondroitin Sulphate Proteoglycans (CSPGs) in perineuronal nets (PNNs) in the visual cortex. This suggests that IGF-1 action in mediating EE effects could be exerted through the modulation of intracortical inhibitory circuitry and PNN development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0000475

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Immunoreactivity for IGF-1 in the developing visual cortex: effects of EE. (A) Typical appearance of IGF-1 positive cells in the developing rat binocular visual cortex Oc1B. Age of the animal, P25, calibration bar 25 µm. (B) Example showing the preponderance of the neuronal phenotype in IGF-1 positive cells in the developing rat binocular visual cortex Oc1B. Age of the animal P18. Staining for IGF-1 green, staining for NeuN (neuronal marker) red, merged image. Calibration bar: 50 µm. (C) Mean number of IGF-1 positive cells in the visual cortex, normalized to the number of neurons (Neu N positive cells) for each developmental age analysed. Black dots are data from EE rats and light grey dots data from non-EE rats. Vertical bars represent SEM. The number of animals analyzed is: for non-EE rats, N = 5 at P15, N = 8 at P18, N = 6 at P21, N = 6 at P25; for EE rats, N = 6 at P15, N = 10 at P18, N = 6 at P21, N = 7 at P25. The normalized number of IGF-1 positive cells increases between P15 and P21 in non-EE rats (Two Way ANOVA, housing (two levels)×age (four levels), factor age significant, p<0,001; post-hoc Tukey's test, p<0,05). In EE rats the normalized number of IGF-1 positive cells increases significantly between P15 and P18; the normalized number at P18 in EE rats is significantly increased with respect to non-EE rats (Two Way ANOVA, housing (two levels)×age (four levels), factor age significant, p<0,001, interaction housing×age significant, p = 0,011; post-hoc Tukey's test, p<0,05). (D) Example of IGF-1 labelling from fields taken in the layers II/III of the rat visual cortex of one P18 EE and one P18 non-EE rat. It is evident the increase in IGF-1 positive cells caused by EE. Calibration bar: 50 µm.
Figure 1 Immunoreactivity for IGF-1 in the developing visual cortex: effects of EE. (A) Typical appearance of IGF-1 positive cells in the developing rat binocular visual cortex Oc1B. Age of the animal, P25, calibration bar 25 µm. (B) Example showing the preponderance of the neuronal phenotype in IGF-1 positive cells in the developing rat binocular visual cortex Oc1B. Age of the animal P18. Staining for IGF-1 green, staining for NeuN (neuronal marker) red, merged image. Calibration bar: 50 µm. (C) Mean number of IGF-1 positive cells in the visual cortex, normalized to the number of neurons (Neu N positive cells) for each developmental age analysed. Black dots are data from EE rats and light grey dots data from non-EE rats. Vertical bars represent SEM. The number of animals analyzed is: for non-EE rats, N = 5 at P15, N = 8 at P18, N = 6 at P21, N = 6 at P25; for EE rats, N = 6 at P15, N = 10 at P18, N = 6 at P21, N = 7 at P25. The normalized number of IGF-1 positive cells increases between P15 and P21 in non-EE rats (Two Way ANOVA, housing (two levels)×age (four levels), factor age significant, p<0,001; post-hoc Tukey's test, p<0,05). In EE rats the normalized number of IGF-1 positive cells increases significantly between P15 and P18; the normalized number at P18 in EE rats is significantly increased with respect to non-EE rats (Two Way ANOVA, housing (two levels)×age (four levels), factor age significant, p<0,001, interaction housing×age significant, p = 0,011; post-hoc Tukey's test, p<0,05). (D) Example of IGF-1 labelling from fields taken in the layers II/III of the rat visual cortex of one P18 EE and one P18 non-EE rat. It is evident the increase in IGF-1 positive cells caused by EE. Calibration bar: 50 µm.CC BY · PubMed Central
Figure 2 IGF-1 administration in the visual cortex accelerates visual acuity development. (A) Experimental protocol. (B) Left, schematic representation of minipump implant and recording site for Visual Evoked Potentials (VEPs). Right, representative waveform of VEP recorded from Oc1B in response to visual stimulation with gratings sinusoidally modulated in contrast at 1Hz. (C) Example of visual acuity estimate in one IGF-1 (red) and one vehicle (light blue) treated animal. Experimental points are VEP amplitudes normalized to the mean amplitude of VEP at 0,2 c/deg; thick lines are linear fits to the data. Estimated visual acuities (arrows) are taken as the extrapolation to 0 level of the fitting line. Waveforms above the graph are the VEP recordings obtained at 0,2 and 0,5 c/deg for the IGF-1 (red) and the vehicle (PBS) treated animal (light blue). It is evident that at the higher spatial frequency response is obtained only in the IGF-1 treated rat. (D) Summary of visual acuity in all groups. Data are mean visual acuity and vertical bars represent SEM. Visual acuity of non-EE IGF-1 treated animals (IGF-1, 0,9±0,08 c/deg, N = 5) is significantly higher than in non-EE vehicle treated animals (PBS, 0,67±0,03 c/deg, N = 6) or in non-EE untreated animals (non-EE 0,63±0,01 c/deg, N = 7); the latter two do not differ (One Way ANOVA, p<0,001; post-hoc Tukey's test, significance level 0,05). The visual acuity in non-EE IGF-1 treated rats do not differ from that in P25 EE rats (EE, 0,93±0,03, N = 4) (One Way ANOVA, post-hoc Tukey's test p>0,05). Asterisks denote significant difference (two asterisks, p<0,01, three asterisks p<0,001).
Figure 2 IGF-1 administration in the visual cortex accelerates visual acuity development. (A) Experimental protocol. (B) Left, schematic representation of minipump implant and recording site for Visual Evoked Potentials (VEPs). Right, representative waveform of VEP recorded from Oc1B in response to visual stimulation with gratings sinusoidally modulated in contrast at 1Hz. (C) Example of visual acuity estimate in one IGF-1 (red) and one vehicle (light blue) treated animal. Experimental points are VEP amplitudes normalized to the mean amplitude of VEP at 0,2 c/deg; thick lines are linear fits to the data. Estimated visual acuities (arrows) are taken as the extrapolation to 0 level of the fitting line. Waveforms above the graph are the VEP recordings obtained at 0,2 and 0,5 c/deg for the IGF-1 (red) and the vehicle (PBS) treated animal (light blue). It is evident that at the higher spatial frequency response is obtained only in the IGF-1 treated rat. (D) Summary of visual acuity in all groups. Data are mean visual acuity and vertical bars represent SEM. Visual acuity of non-EE IGF-1 treated animals (IGF-1, 0,9±0,08 c/deg, N = 5) is significantly higher than in non-EE vehicle treated animals (PBS, 0,67±0,03 c/deg, N = 6) or in non-EE untreated animals (non-EE 0,63±0,01 c/deg, N = 7); the latter two do not differ (One Way ANOVA, p<0,001; post-hoc Tukey's test, significance level 0,05). The visual acuity in non-EE IGF-1 treated rats do not differ from that in P25 EE rats (EE, 0,93±0,03, N = 4) (One Way ANOVA, post-hoc Tukey's test p>0,05). Asterisks denote significant difference (two asterisks, p<0,01, three asterisks p<0,001).CC BY · PubMed Central
Figure 3 IGF-1 blockade prevents the acceleration of visual acuity development in enriched animals. (A) Experimental protocol and schematic representation of minipump implant and recording site for VEPs. (B) Example of visual acuity estimated in one JB1 treated EE rat (EE-JB1, blue) and one vehicle treated EE animal (EE-PBS, green). Experimental points are normalized VEP amplitudes; thick lines are linear fits to the data. Estimated visual acuities are indicated by arrows. Waveforms above the graph are VEPs recorded in response to visual stimulation with gratings of spatial frequencies 0,2 and 0,5 c/deg for the JB1 treated (blue) and the vehicle treated EE animal (green). It is evident that at the higher spatial frequency a response is obtained only in the vehicle treated EE rat. (C) Summary of mean visual acuity in all JB1 (0,55±0,05 c/deg, N = 5) and PBS treated (0,81±0,07 c/deg, N = 4) P25 EE animals; data for P25 EE and non-EE rats are replotted from Fig. 2 for comparison. Vertical bars represent SEM. Visual acuity of JB1 treated EE animals is significantly lower than in EE animals either treated with vehicle or untreated and does not differ from the visual acuity of P25 non-EE rats (One Way ANOVA, p<0,001; post-hoc Tukey's test, significance level 0,05). Asterisks denote significant difference (one asterisk, p<0,05; two asterisks, p<0,01; three asterisks, p<0,001).
Figure 3 IGF-1 blockade prevents the acceleration of visual acuity development in enriched animals. (A) Experimental protocol and schematic representation of minipump implant and recording site for VEPs. (B) Example of visual acuity estimated in one JB1 treated EE rat (EE-JB1, blue) and one vehicle treated EE animal (EE-PBS, green). Experimental points are normalized VEP amplitudes; thick lines are linear fits to the data. Estimated visual acuities are indicated by arrows. Waveforms above the graph are VEPs recorded in response to visual stimulation with gratings of spatial frequencies 0,2 and 0,5 c/deg for the JB1 treated (blue) and the vehicle treated EE animal (green). It is evident that at the higher spatial frequency a response is obtained only in the vehicle treated EE rat. (C) Summary of mean visual acuity in all JB1 (0,55±0,05 c/deg, N = 5) and PBS treated (0,81±0,07 c/deg, N = 4) P25 EE animals; data for P25 EE and non-EE rats are replotted from Fig. 2 for comparison. Vertical bars represent SEM. Visual acuity of JB1 treated EE animals is significantly lower than in EE animals either treated with vehicle or untreated and does not differ from the visual acuity of P25 non-EE rats (One Way ANOVA, p<0,001; post-hoc Tukey's test, significance level 0,05). Asterisks denote significant difference (one asterisk, p<0,05; two asterisks, p<0,01; three asterisks, p<0,001).CC BY · PubMed Central
Figure 4 IGF-1 affects intracortical inhibition and perineuronal nets (PNNs) in the developing visual cortex. (A) Left, representative example of GAD65 immunoreactivity in the rat visual cortex at P25. It is evident the punctate nature of the staining around cell bodies (puncta-ring). To quantify GAD65 immunoreactivity in puncta rings, immunofluorescence in puncta ring was normalized to background signal. Calibration bar 20 µm. Right: light bar: percentage variation of GAD65 puncta ring immunoreactivity between the cortex implanted at P18 with a IGF-1 filled minipump and the cortex implanted with a PBS filled minipump in P25 non-EE animals (N = 7). Percentage variation computed as [(GAD65 immunoreactivity in IGF-1 treated/GAD65 immunoreactivity in PBS treated cortex) –1]×100. GAD65 immunoreactivity is significantly higher in the IGF-1 treated than in the PBS treated cortex (paired t-test, p<0,05, one asterisk). Right, dark bar: Percentage variation of GAD65 puncta ring immunoreactivity between the cortex implanted at P18 with a JB1 filled minipump and the cortex implanted with a PBS filled minipump in P25 EE animals (N = 5). Percentage variation computed as [(GAD65 immunoreactivity in JB1 treated/GAD65 immunoreactivity in PBS treated cortex) –1]×100. GAD65 immunoreactivity is significantly lower in the JB1 treated than in the PBS treated cortex (paired t-test, p<0,05, one asterisk). Vertical bars indicate SEM. (B) Left, representative example of WFA staining (green) and NeuN staining (red) merged image in the rat visual cortex at P25. WFA stained PNN completely surround cortical neurons. Calibration bar 50: µm. Right, leftmost: PNN surrounded cells (WFA positive cells/NeuN positive cells) are more numerous in the visual cortex treated from P18 to P25 with IGF-1 than in the contralateral, PBS treated cortex of non-EE animals (N = 5 animals, paired t-test, p<0,01, two asterisks). Right, rightmost: PNN surrounded cells (WFA positive cells/NeuN positive cells) are less numerous in the visual cortex treated from P18 to P25 with JB1 than in the contralateral, PBS treated cortex of EE animals (N = 6 animals, paired t-test, p<0,05, one asterisks). Vertical bars represent SEM.
Figure 4 IGF-1 affects intracortical inhibition and perineuronal nets (PNNs) in the developing visual cortex. (A) Left, representative example of GAD65 immunoreactivity in the rat visual cortex at P25. It is evident the punctate nature of the staining around cell bodies (puncta-ring). To quantify GAD65 immunoreactivity in puncta rings, immunofluorescence in puncta ring was normalized to background signal. Calibration bar 20 µm. Right: light bar: percentage variation of GAD65 puncta ring immunoreactivity between the cortex implanted at P18 with a IGF-1 filled minipump and the cortex implanted with a PBS filled minipump in P25 non-EE animals (N = 7). Percentage variation computed as [(GAD65 immunoreactivity in IGF-1 treated/GAD65 immunoreactivity in PBS treated cortex) –1]×100. GAD65 immunoreactivity is significantly higher in the IGF-1 treated than in the PBS treated cortex (paired t-test, p<0,05, one asterisk). Right, dark bar: Percentage variation of GAD65 puncta ring immunoreactivity between the cortex implanted at P18 with a JB1 filled minipump and the cortex implanted with a PBS filled minipump in P25 EE animals (N = 5). Percentage variation computed as [(GAD65 immunoreactivity in JB1 treated/GAD65 immunoreactivity in PBS treated cortex) –1]×100. GAD65 immunoreactivity is significantly lower in the JB1 treated than in the PBS treated cortex (paired t-test, p<0,05, one asterisk). Vertical bars indicate SEM. (B) Left, representative example of WFA staining (green) and NeuN staining (red) merged image in the rat visual cortex at P25. WFA stained PNN completely surround cortical neurons. Calibration bar 50: µm. Right, leftmost: PNN surrounded cells (WFA positive cells/NeuN positive cells) are more numerous in the visual cortex treated from P18 to P25 with IGF-1 than in the contralateral, PBS treated cortex of non-EE animals (N = 5 animals, paired t-test, p<0,01, two asterisks). Right, rightmost: PNN surrounded cells (WFA positive cells/NeuN positive cells) are less numerous in the visual cortex treated from P18 to P25 with JB1 than in the contralateral, PBS treated cortex of EE animals (N = 6 animals, paired t-test, p<0,05, one asterisks). Vertical bars represent SEM.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 119

Metadata

Authors
Ciucci, F., Putignano, E., Baroncelli, L., Landi, S., Berardi, N., & Maffei, L.
Affiliations
  • Scuola Normale Superiore (IT)
  • Neuroscience Institute (IT)
Corresponding author
Ciucci, Francesca
Venue
PLoS ONE
Published
2007-05-30
Volume
2
Issue
5
Pages
e475
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2010543931
Cited by
119
References
60
Citations by year
2026: 2 · 2025: 6 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 9 · 2019: 7 · 2018: 6 · 2017: 12 · 2016: 7 · 2015: 3 · 2014: 11 · 2013: 3 · 2012: 12
FWCI
1.95
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
Ministero dell’Istruzione, dell’Università e della Ricerca
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Visual perception and processing mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
insulin-like growth factor I, environmental enrichment, visual cortex development, visual acuity, visual evoked potentials, GAD65, perineuronal nets, chondroitin sulfate proteoglycans, dark rearing, cortical inhibition
MeSH terms
Animals, Evoked Potentials, Visual, Immunohistochemistry, Insulin-Like Growth Factor I, Neurons, Visual Acuity, Visual Cortex, Rats, Long-Evans, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin-Like Growth Factor 1 (IGF-1) Mediates the Effects of Enriched Environment (EE) on Visual Cortical Development. https://app.cochat.ai/papers/10.1371/journal.pone.0000475
The paper
Ciucci, F., Putignano, E., Baroncelli, L., Landi, S., Berardi, N., & Maffei, L. (2007). Insulin-Like Growth Factor 1 (IGF-1) Mediates the Effects of Enriched Environment (EE) on Visual Cortical Development. PLoS ONE. https://doi.org/10.1371/journal.pone.0000475

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.